Novatti - The $1 party, page-1307

The acquisition of RKN was the final hurdle NOV needed to complete the process and tick all the boxes- without the reckon deal it would have been delayed- APRA changed the regulation process where you need a profitable business paying dividends- Reckon ticked that box along with the sheer amount of SME on their base (along with BC Banking of course).

I still believe $1 is selling yourself short, here’s why.

APRA Banking licenses are going to be near impossible to get these days with companies with the MC of Novatti, simply this just doesn’t happen without an IPO and institutional funding.
In my opinion, this commands a $250M-$300M MC.
If we also add the current business with current transactional agreements along with Emersion kicking off, we can add a further $160-$250M to this.

My forecast tally by Christmas providing APRA approve our license $450-$500M MC.

$450M MC = $1.38 (based of current sp of .48c)

$500M MC = $1.50 - this is my forecast (there will be many material announcements due by Christmas along with the license to hit this target).


The low volatility as of the last 2 months indicates to me NOV sentiment is extremely high, for a small cap this is extremely rare. Hold tight and patients will pay off